These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9755436)

  • 1. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
    Kelty NL; Holder LE; Khan SH
    J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.
    Hardie AD; Rieter WJ; Bradshaw ML; Gordon LL; Young MA; Keane TE
    World J Urol; 2013 Dec; 31(6):1327-32. PubMed ID: 23595605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical considerations for acquiring and processing indium-111 capromab pendetide images.
    Williams BS; Hinkle GH; Lamatrice RA; Fry JP; Loesch JA; Olsen JO
    J Nucl Med Technol; 1997 Sep; 25(3):205-16. PubMed ID: 9291068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using vascular structure for CT-SPECT registration in the pelvis.
    Hamilton RJ; Blend MJ; Pelizzari CA; Milliken BD; Vijayakumar S
    J Nucl Med; 1999 Feb; 40(2):347-51. PubMed ID: 10025845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in SPECT/CT imaging of prostate cancer.
    Seo Y; Franc BL; Hawkins RA; Wong KH; Hasegawa BH
    Technol Cancer Res Treat; 2006 Aug; 5(4):329-36. PubMed ID: 16866563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
    Rosenthal SA; Haseman MK; Polascik TJ
    Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
    Valliappan S; Joyce JM; Myers DT
    Clin Nucl Med; 1999 Dec; 24(12):984-5. PubMed ID: 10595486
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.
    Manyak MJ; Hinkle GH; Olsen JO; Chiaccherini RP; Partin AW; Piantadosi S; Burgers JK; Texter JH; Neal CE; Libertino JA; Wright GL; Maguire RT
    Urology; 1999 Dec; 54(6):1058-63. PubMed ID: 10604708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capromab pendetide imaging of occult lymph node metastases.
    Haseman MK
    J Nucl Med; 1998 Apr; 39(4):653. PubMed ID: 9544674
    [No Abstract]   [Full Text] [Related]  

  • 12. The dual-isotope ProstaScint imaging procedure: clinical experience and staging results in 145 patients.
    Quintana JC; Blend MJ
    Clin Nucl Med; 2000 Jan; 25(1):33-40. PubMed ID: 10634528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Neal CE; Texter JH; Kahn D; Williams RD; Maguire R; Rogers B; Olsen JO; Badalament RA
    Cancer; 1998 Aug; 83(4):739-47. PubMed ID: 9708939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.
    Schettino CJ; Kramer EL; Noz ME; Taneja S; Padmanabhan P; Lepor H
    AJR Am J Roentgenol; 2004 Aug; 183(2):519-24. PubMed ID: 15269050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Olsen JO; Williams BS; Lamatrice RA; Barth RF; Rogers B; Maguire RT
    J Nucl Med; 1998 Apr; 39(4):650-2. PubMed ID: 9544673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indium-111-capromab pendetide scans: an important test relevant to clinical decision making.
    Sartor O; McLeod D
    Urology; 2001 Mar; 57(3):399-401. PubMed ID: 11248605
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
    Seo Y; Aparici CM; Cooperberg MR; Konety BR; Hawkins RA
    J Nucl Med; 2010 Jan; 51(1):31-6. PubMed ID: 20008977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
    Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
    J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging.
    Manyak MJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):127-30. PubMed ID: 10803317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.